Allosteric modulators affect the internalization of human adenosine A1 receptors

被引:15
作者
Klaasse, EC
van den Hout, G
Roerink, SF
de Grip, WJ
IJzerman, AP
Beukers, MW
机构
[1] Leiden Univ, Dept Med Chem, Leiden Amsterdam Ctr Drug Res, NL-2300 RA Leiden, Netherlands
[2] Leiden Univ, Dept Biophys Organ Chem, Leiden Amsterdam Ctr Drug Res, Leiden Inst Chem, NL-2300 RA Leiden, Netherlands
关键词
internalization; allosteric modulation; PD 81,723; SCH-202676; human adenosine A(1) receptor; YFP;
D O I
10.1016/j.ejphar.2005.08.052
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
To study the effect of allosteric modulators on the internalization of human adenosine A, receptors, the receptor was equipped with a C-terminal yellow fluorescent protein tag. The introduction of this tag did not affect the radioligand binding properties of the receptor. CHO cells stably expressing this receptor were subjected during 16 It to varying concentrations of the agonist N-6-cyclopentyladenosine (CPA) in the absence or presence of 10 mu M of the allosteric enhancer PD 81,723 ((2-amino-4,5-dimethyl-3-thienyl)-[3-(trifluoromethyl)phenyl]methanone) or the allosteric inhibitor SCH-202676 (N-(2,3-diphenyl-1,2,4-thiadiazol-5(2H)-ylidene)methanamine). CPA itself was able to internalize 25% and 40% of the receptors at a concentration of 400 nM or 4 mu M, respectively. Addition of either PD 81,723 or SCH-202676 alone had no effect on internalization. However, with PD 81,723 a slight amount of internalization was obtained already at 40 nM of CPA and at 400 nM CPA 59% of the receptors internalized. SCH-202676 on the other hand effectively prevented CPA-induced internalization of the receptor. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 27 条
[1]  
BATTACHARYA S, 1996, MOL PHARMACOL, V50, P104
[2]   Random mutagenesis of the human adenosine A2B receptor followed by growth selection in yeast.: Identification of constitutively active and gain of function mutations [J].
Beukers, MW ;
van Oppenraaij, J ;
van der Hoorn, PPW ;
Blad, CC ;
den Dulk, H ;
Brouwer, J ;
IJzerman, AP .
MOLECULAR PHARMACOLOGY, 2004, 65 (03) :702-710
[3]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[4]   G protein-coupled receptor allosterism and complexing [J].
Christopoulos, A ;
Kenakin, T .
PHARMACOLOGICAL REVIEWS, 2002, 54 (02) :323-374
[5]   Ligand-induced phosphorylation, clustering, and desensitization of A(1) adenosine receptors [J].
Ciruela, F ;
Saura, C ;
Canela, EI ;
Mallol, J ;
Lluis, C ;
Franco, R .
MOLECULAR PHARMACOLOGY, 1997, 52 (05) :788-797
[6]   Thermodynamics of full agonist, partial agonist, and antagonist binding to wild-type and mutant adenosine A1 receptors [J].
Dalpiaz, A ;
Townsend-Nicholson, A ;
Beukers, MW ;
Schofield, PR ;
IJzerman, AP .
BIOCHEMICAL PHARMACOLOGY, 1998, 56 (11) :1437-1445
[7]   Ligand-induced caveolae-mediated internalization of A1 adenosine receptors:: morphological evidence of endosomal sorting and receptor recycling [J].
Escriche, M ;
Burgueño, J ;
Ciruela, F ;
Canela, EI ;
Mallol, J ;
Enrich, C ;
Lluís, C ;
Franco, R .
EXPERIMENTAL CELL RESEARCH, 2003, 285 (01) :72-90
[8]   SCH-202676: An allosteric modulator of both agonist and antagonist binding to G protein-coupled receptors [J].
Fawzi, AB ;
Macdonald, D ;
Benbow, LL ;
Smith-Torhan, A ;
Zhang, HT ;
Weig, BC ;
Ho, G ;
Tulshian, D ;
Linder, ME ;
Graziano, MP .
MOLECULAR PHARMACOLOGY, 2001, 59 (01) :30-37
[9]   Subtype-specific kinetics of inhibitory adenosine receptor internalization are determined by sensitivity to phosphorylation by G protein-coupled receptor kinases [J].
Ferguson, G ;
Watterson, KR ;
Palmer, TM .
MOLECULAR PHARMACOLOGY, 2000, 57 (03) :546-552
[10]  
Fredholm BB, 2001, PHARMACOL REV, V53, P527